Mirum Pharmaceuticals, Inc
Price
OptionsOpen the Sheet →FilingsNewest: 8-K, Other eventsSep 28 →Insiders1 insider bought $9.0M in 1 open-market buy. 7 insiders sold $28.0M, 21 of 40 sales on a 10b5-1 plan.→HoldersFrazier Life Sciences 11.9%Jupiter Topco 9.1%BlackRock 6.8%→Financing →PeersClosest companies: PTCT, BMRN, VRDN→
From the filings
Figures
- Revenue
- $618.1Mlast 12 months
- Net income
- −$860.2Mlast 12 months
- Operating cash flow
- −$171.0Mlast 12 months
- Cash and equivalents
- $330.7Mat the last balance sheet
- Shares outstanding
- 64.8M shareson issue